These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1311964)

  • 21. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.
    Pigott TA; Zohar J; Hill JL; Bernstein SE; Grover GN; Zohar-Kadouch RC; Murphy DL
    Biol Psychiatry; 1991 Mar; 29(5):418-26. PubMed ID: 2018816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias.
    Stein DJ; Hollander E; Anthony DT; Schneier FR; Fallon BA; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1992 Aug; 53(8):267-71. PubMed ID: 1386848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroendocrine responses to single doses of buspirone in obsessive-compulsive disorder.
    Norman TR; Apostolopoulos M; Burrows GD; Judd FK
    Int Clin Psychopharmacol; 1994; 9(2):89-94. PubMed ID: 8056999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology.
    Zohar J; Insel TR
    Biol Psychiatry; 1987 Jun; 22(6):667-87. PubMed ID: 3036259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls.
    Zohar J; Mueller EA; Insel TR; Zohar-Kadouch RC; Murphy DL
    Arch Gen Psychiatry; 1987 Nov; 44(11):946-51. PubMed ID: 3675134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
    Goodman WK; Price LH; Delgado PL; Palumbo J; Krystal JH; Nagy LM; Rasmussen SA; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of age and gender on CNS serotonergic responsivity in normal adults.
    McBride PA; Tierney H; DeMeo M; Chen JS; Mann JJ
    Biol Psychiatry; 1990 May; 27(10):1143-55. PubMed ID: 2340323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
    O'Keane V; Dinan TG
    Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissecting the Yale-Brown Obsessive-Compulsive Scale severity scale to understand the routes for symptomatic improvement in obsessive-compulsive disorder.
    Costa DLDC; Barbosa VS; Requena G; Shavitt RG; Pereira CAB; Diniz JB
    J Psychopharmacol; 2017 Oct; 31(10):1312-1322. PubMed ID: 28441896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of obsessions and compulsions in patients with anorexia nervosa and obsessive compulsive disorder.
    Bastiani AM; Altemus M; Pigott TA; Rubenstein C; Weltzin TE; Kaye WH
    Biol Psychiatry; 1996 Jun; 39(11):966-9. PubMed ID: 9162209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonergic regulation of prolactin and growth hormone secretion in man.
    Lewis DA; Sherman BM
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):152-7. PubMed ID: 4060968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of fenfluramine on sleep and prolactin in depressed inpatients: a comparison of potential indices of brain serotonergic responsivity.
    Myers JE; Buysse DJ; Thase ME; Perel J; Miewald JM; Cooper TB; Kupfer DJ; Mann JJ
    Biol Psychiatry; 1993 Dec; 34(11):753-8. PubMed ID: 8292678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased prolactin responses to d-fenfluramine in obsessive-compulsive disorder.
    Ramasubbu R
    Br J Psychiatry; 1998 Feb; 172():186-7. PubMed ID: 9519076
    [No Abstract]   [Full Text] [Related]  

  • 34. Impulsivity and serotonergic function in compulsive personality disorder.
    Stein DJ; Trestman RL; Mitropoulou V; Coccaro EF; Hollander E; Siever LJ
    J Neuropsychiatry Clin Neurosci; 1996; 8(4):393-8. PubMed ID: 9116474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings.
    Hollander E; Fay M; Cohen B; Campeas R; Gorman JM; Liebowitz MR
    Am J Psychiatry; 1988 Aug; 145(8):1015-7. PubMed ID: 2839998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cigarette smoking decreases the prolactin response to serotonergic stimulation in subgroups of alcoholics and controls.
    Anthenelli RM; Maxwell RA
    Alcohol Clin Exp Res; 2000 Jul; 24(7):987-95. PubMed ID: 10924001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review.
    Newman ME; Shapira B; Lerer B
    Int J Neuropsychopharmacol; 1998 Jul; 1(1):49-69. PubMed ID: 11281946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.
    Lucey JV; O'Keane V; Butcher G; Clare AW; Dinan TG
    Br J Psychiatry; 1992 Oct; 161():517-21. PubMed ID: 1393339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comorbid psychopathology and clinical symptomatology in children and adolescents with obsessive-compulsive disorder.
    Anagnostopoulos DC; Korlou S; Sakellariou K; Kondyli V; Sarafidou J; Tsakanikos E; Giannakopoulos G; Liakopoulou M
    Psychiatriki; 2016; 27(1):27-36. PubMed ID: 27110880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in obsessive-compulsive disorder patients.
    Kawano A; Tanaka Y; Ishitobi Y; Maruyama Y; Ando T; Inoue A; Okamoto S; Imanaga J; Kanehisa M; Higuma H; Ninomiya T; Tsuru J; Akiyoshi J
    Psychiatry Res; 2013 Aug; 209(1):85-90. PubMed ID: 23266021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.